期刊
BRITISH JOURNAL OF CANCER
卷 92, 期 9, 页码 1599-1610出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6602550
关键词
biomarker; magnetic resonance; therapeutic trials; antiangiogenic; antivascular; cancer therapy
类别
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据